1573 related articles for article (PubMed ID: 8141877)
41. [Recent progress in the chemotherapy of malignant lymphoma].
Tobinai K
Gan To Kagaku Ryoho; 1995 Mar; 22(4):437-43. PubMed ID: 7887635
[TBL] [Abstract][Full Text] [Related]
42. How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
Zinzani PL; Martelli M; Magagnoli M; Zaja F; Storti S; Pavone E; Lauta VM; De Renzo A; Gobbi M; Bocchia M; Ronconi F; Scaramucci L; Gherlinzoni F; Palombi F; Bendandi M; Stefoni V; Anticoli Borza P; Cellini C; Mandelli F; Tura S
Haematologica; 1999 Nov; 84(11):996-1001. PubMed ID: 10553159
[TBL] [Abstract][Full Text] [Related]
43. Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
Bastion Y; Blay JY; Divine M; Brice P; Bordessoule D; Sebban C; Blanc M; Tilly H; Lederlin P; Deconinck E; Salles B; Dumontet C; Brière J; Coiffier B
J Clin Oncol; 1997 Aug; 15(8):2945-53. PubMed ID: 9256139
[TBL] [Abstract][Full Text] [Related]
44. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
45. Applicability of international prognostic index in non Hodgkin's lymphoma in Pakistan.
Aziz Z; Sana S; Saeed S; Akram M
J Ayub Med Coll Abbottabad; 2004; 16(2):15-20. PubMed ID: 15455610
[TBL] [Abstract][Full Text] [Related]
46. Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma.
Aref A; Narayan S; Tekyi-Mensah S; Varterasian M; Dan M; Eilender D; Karanes C; al-Katib A
Radiat Oncol Investig; 1999; 7(3):186-91. PubMed ID: 10406061
[TBL] [Abstract][Full Text] [Related]
47. Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.
Meerwaldt JH; Carde P; Somers R; Thomas J; Kluin-Nelemans JC; Bron D; Noordijk EM; Cosset JM; Bijnens L; Teodorovic I; Hagenbeek A
Ann Oncol; 1997; 8 Suppl 1():67-70. PubMed ID: 9187434
[TBL] [Abstract][Full Text] [Related]
48. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.
Link MP; Shuster JJ; Donaldson SS; Berard CW; Murphy SB
N Engl J Med; 1997 Oct; 337(18):1259-66. PubMed ID: 9345074
[TBL] [Abstract][Full Text] [Related]
49. [Analysis for clinicopathological features, therapy and prognosis of 30 elderly patients with non-Hodgkin's lymphoma].
Wang HT; Yang B; Cai LL; Ran HH; Zhang WY; Zhu HL; Yang Y; Li SX; Fan H; Chi XH; Yu RL; Zhang F; Li BL; Lin J; Zhai B; Yao SQ; Lu XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1464-70. PubMed ID: 24370030
[TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics of and response to combination chemotherapy and subsequent application of international prognostic index in non-Hodgkin's lymphoma--an experience from a medical center in Southern Taiwan.
Hsieh CI; Su WC; Chien CH; Cuo YL; Chen TY; Kao RH; Tsao CJ
Kaohsiung J Med Sci; 1996 Feb; 12(2):69-82. PubMed ID: 8709176
[TBL] [Abstract][Full Text] [Related]
51. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
[TBL] [Abstract][Full Text] [Related]
52. Group risk classification of non-Hodgkin's lymphoma.
Avilés A; Díaz-Maqueo JC; Rodríguez L; García EL; Torras V; Guzmán R
Arch Invest Med (Mex); 1990; 21(1):11-6. PubMed ID: 1699503
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors in localized aggressive non-Hodgkin's lymphoma.
Alici S; Bavbek SE; Kaytan E; Eralp Y; Onat H
Am J Clin Oncol; 2003 Feb; 26(1):1-5. PubMed ID: 12576915
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors in Hodgkin's and non-Hodgkin's lymphomas.
Coiffier B
Curr Opin Oncol; 1991 Oct; 3(5):843-51. PubMed ID: 1751578
[TBL] [Abstract][Full Text] [Related]
55. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.
Sasaki K; Niitsu N
Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project.
Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
Med Pediatr Oncol; 1990; 18(2):89-96. PubMed ID: 2406556
[TBL] [Abstract][Full Text] [Related]
57. Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project.
Ann Oncol; 1997 Oct; 8(10):973-8. PubMed ID: 9402170
[TBL] [Abstract][Full Text] [Related]
58. Aggressive non-Hodgkin's lymphoma treated at the Institute of Oncology, Istanbul: treatment, outcome, and prognostic factors.
Alici S; Bavbek SE; Kaytan E; Başaran M; Eralp Y; Onat H
Am J Clin Oncol; 2002 Oct; 25(5):502-8. PubMed ID: 12393993
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
[TBL] [Abstract][Full Text] [Related]
60. The outcome of > or = 70-year-old non-Hodgkin's lymphoma patients.
Salminen EK
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):349-53. PubMed ID: 7751176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
